Product Information
SULFACETAMIDE 10% EYE DROPS is a generic product labeled by Bausch & Lomb Incorporated, priced at $1.9619 per ML under NDC 24208067004. Its NADAC has been published 671 times since Nov 28, 2013.
FDA first approved this application on Dec 28, 1994. Its Orange Book therapeutic-equivalence code is AT.
Strength
100 mg/mL
Manufacturer
Bausch & Lomb IncorporatedNDC
24208067004
Classification
Generic
Dosage Form
SOLUTION/ DROPS
Route
OPHTHALMIC
Effective Date
9/23/2026
Active Ingredients
SULFACETAMIDE SODIUMApproval Type
Generic (ANDA)
FDA Application
ANDA040066FDA Approved
12/28/1994
TE Code
AT
On Market Since
12/28/1994
Pharmacological Classes
Price Statistics
The NADAC for SULFACETAMIDE 10% EYE DROPS has been published 671 times since Nov 28, 2013, and over the history we have for it it has declined 32.6%. The table below summarizes its recorded NADAC range and movement.
| Current price | $1.9619 per ML |
|---|---|
| All-time high | $3.0346 (Sep 14, 2016) |
| All-time low | $1.7515 (Nov 20, 2024) |
| 52-week high | $2.1113 |
| 52-week low | $1.8512 |
| Median price | $2.3932 |
| Average price | $2.4313 |
| Largest weekly change | +35.8% (Mar 17, 2021) |
| Weeks tracked | 671 |
| Tracking since | Nov 28, 2013 |
Generic Alternatives
No other NADAC-published product shares this drug's active ingredient and strength in a comparable dosage form. Compare the broader picture on the sulfacetamide sodium market page.
Lowest-Cost Alternatives
No alternatives available
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
Bausch & Lomb Incorporated manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
sulfacetamide sodium market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Therapeutic class
Sulfonamide Antibacterial class view
See how this drug behaves alongside other products in the same FDA pharmacologic class.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of SULFACETAMIDE 10% EYE DROPS?
The current National Average Drug Acquisition Cost (NADAC) for SULFACETAMIDE 10% EYE DROPS, manufactured by Bausch & Lomb Incorporated, is $1.9619 per ML (NDC 24208067004), effective Sep 30, 2026.
How has the price of SULFACETAMIDE 10% EYE DROPS changed over time?
Over the history we have for it, the NADAC for SULFACETAMIDE 10% EYE DROPS has declined 32.6%. It has been tracked across 671 weekly CMS publications since Nov 28, 2013.
What are the highest and lowest recorded NADAC prices for SULFACETAMIDE 10% EYE DROPS?
Since Nov 28, 2013, the NADAC for SULFACETAMIDE 10% EYE DROPS has ranged from a low of $1.7515 (Nov 20, 2024) to a high of $3.0346 (Sep 14, 2016), with a median of $2.3932 per ML.
Are there cheaper alternatives to SULFACETAMIDE 10% EYE DROPS?
No other NADAC-published product currently shares the active ingredient and strength of SULFACETAMIDE 10% EYE DROPS in a comparable dosage form, so no direct lower-cost alternative is listed.
Who manufactures SULFACETAMIDE 10% EYE DROPS?
SULFACETAMIDE 10% EYE DROPS (NDC 24208067004) is labeled by Bausch & Lomb Incorporated, and CMS classifies it as a generic product.